Stock Rich List
#9629 on the rich list of 14,644 insiders

John L. Lamattina

Director at Ligand Pharmaceuticals; Director at Immunome. Based in Jupiter, Florida.

$8.9M
in disclosed stock, −$329K (−3.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
9629th of 14,644
Companies held
2
Largest holding
LGND, 87.4% of total
Latest SEC filing
Jun 10, 2026

What the $8.9M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Ligand Pharmaceuticals LGND
Common Stock
Directly26,969$286.94$7.7M87.4%Form 4, Jun 10, 2026
Immunome IMNM
Common Stock
Directly66,953$16.61$1.1M12.6%Form 4, Jan 15, 2023

Share counts are the amounts John L. Lamattina reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Jun 10, 2026SoldLGND257$247.22$64KView
Jun 10, 2026SoldLGND3,405$251.62$857KView
Jun 10, 2026SoldLGND697$249.53$174KView
Jun 10, 2026SoldLGND232$248.11$58KView
Mar 6, 2026SoldLGND2,161$200.76$434KView
Nov 7, 2025SoldLGND2,034$205.45$418KView
Nov 7, 2025SoldLGND2,145$205.45$441KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
9626Jeffrey K. Li
SVP and Secretary, Keysight Technologies. Santa Rosa, CA
$8.9M−$154K (−1.70%)
9627John G. Freund
Director, SI-BONE. Santa Clara, CA
$8.9M−$31K (−0.35%)
9628Mariani Gustavo
Vice President, Pampa Energía
$8.9M−$54K (−0.61%)
9629John L. Lamattina
Director, Ligand Pharmaceuticals. Jupiter, FL
$8.9M−$329K (−3.58%)
9630Ryan F. Urness
SVP, GC & Secretary, Dycom Industries. West Palm Beach, FL
$8.8M−$177K (−1.96%)
9631Robert A Cashell Jr
Director, Glacier Bancorp. Kalispell, MT
$8.8M−$135K (−1.50%)
9632Bruce John Essex Jr.
Director, ChoiceOne Financial Services. Sparta, MI
$8.8M−$133K (−1.48%)

Other Ligand Pharmaceuticals insiders

All LGND insiders

Questions

How much stock does John L. Lamattina own?

John L. Lamattina holds $8,850,574 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 9629th on the Stock Rich List.

Is this John L. Lamattina's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did John L. Lamattina last buy or sell stock?

The most recent open-market trade on file is a sale of 257 LGND shares on Jun 10, 2026 at $247.22.